AIHW Board AIHW senior staff Annual report Capability statement Collaboration AIHW corporate plan 2015-16 to 2018-19 Customer care charter FOI - freedom of information Indexed list of files Organisation chart Presentations Privacy of data Public consultation Public Interest Disclosure Strategic Directions 2011-2014 Tenders
By category Ageing, disability & carers Families & children Hospitals Housing & homelessness Indigenous Australians Population groups Risk factors, diseases & death Services, workforce & spending
By subject Adoptions Aged care Ageing Alcohol & other drugs Arthritis & musculoskeletal conditions Asthma Australia's health Australia's welfare Burden of disease Cancer Cardiovascular disease Child health, development & wellbeing Child protection Children's services Chronic diseases
Chronic kidney disease Chronic respiratory conditions COPD Deaths Dementia Dental & oral health Diabetes Disability Expenditure Eye health Food & nutrition Health indicators Homelessness Hospitals Housing assistance Indigenous Australians Injury Life expectancy
Male health Mental health Mothers & babies National health priority areas Overweight & obesity Palliative care Population health Prisoner health Risk factors Rural health Safety & quality of health care Veterans' health Workforce Youth health & wellbeing Youth justice
In other sections Data Publications Contact AIHW
Publications CatalogueOrdering publicationsForthcoming publicationsOnline reportsRate our publication effectivenessSubscribe to release notices
By subject Adoptions Aged care Ageing Alcohol & other drugs Arthritis & musculoskeletal conditions Asthma Australia's health Australia's welfare Burden of disease Cancer Cardiovascular disease Child health, development & wellbeing Child protection Children's services Chronic diseases Chronic kidney disease
Chronic respiratory conditions Corporate publications Data linkage Data standards Deaths Dental & oral health Diabetes Disability Expenditure Eye health Food & nutrition General practice Health indicators Homelessness Hospitals Housing assistance Indigenous Australians Indigenous housing
Injury Life expectancy Male health Mental health services Mothers & babies National health priority areas Overweight & obesity Palliative care Population health Prisoner health Risk factors Rural health Safety & quality of health care Veterans' health Workforce Youth health & wellbeing Youth justice
In other sections Subjects Data Contact AIHW
About AIHW data METeOR—metadata online registry Data by subject Catalogue of holdings of AIHW data Customised data analysis request Data governance framework Data linking Data standards GovHack Privacy of data Accessing Australian Government health and welfare data
By subjectAboriginal and Torres Strait Islander Health Performance Framework Adoptions Aged care Alcohol and other drugs Alcohol data sources Body weight data sources Cancer Children's headline indicators (CHI) Child protection Chronic disease indicators Data sources for monitoring health conditionsDeaths Disability
Expenditure FHBH - Fixing houses for better health General practice (GP) data Height and weight data sources Hospitals Indigenous Australians International collaboration Maternity Information Matrix (MIM) Medical indemnity Mental health National Aged Care Data Clearinghouse
National core maternity indicators (NCMI) National framework for protecting Australia’s children (NFPAC) National indicator catalogue National Youth Information Framework (NYIF) Perinatal data Risk factors statistics Specialist Homelessness Services (SHS) Tobacco data sources Workforce
In other sections Subjects Publications Contact AIHW
AACR ACFADD AHSAC AIHW Board AIHW Ethics Committee AODTS NMDS WG CKDMAC CMAG CSDWG CVDMAC HEAC HHIMG
IGIHM JJ RIG MHISSC NAGATSIHID NCIAG NCSIMG NDDWG NDIMG NHISSC NIAG NIRAPIMG NMDD
NMDS NMHPSC NOPSAD NPDDC NPHEP NPHIC PCDWG PDWG PHIDG PHIG REDWG Workforce committees YIAG
Education worksheets Infographics What's in the pipeline Subscribe to education notices Other educational links
Worksheets by subject All Latest Ageing Australia's health Australia's welfare Carers
Children & youth Disability Disease Drugs
Health Health prevention Indigenous Australians Injury
In other sections Subjects Data Publications Contact AIHW
Job vacancies How to apply for a position at the AIHW Conditions of employment Benefits of working for the AIHW Temporary employment register Occupational Training Program Contact the People Unit Graduates
AIHW Access magazine Media releases Subscribe to release notices Media FAQ Media contacts
You are here:
More prescribers are available for people seeking opioid
pharmacotherapy drug treatment, according to a report released
today by the Australian Institute of Health and Welfare (AIHW).
Dependence on opioid drugs, such as heroin and morphine, is
often treated with an opioid pharmacotherapy drug, such as
methadone, which can reduce drug cravings, improve physical and
mental health and reduce drug-related crime.
The report, National Opioid Pharmacotherapy Statistics
2013, shows that on a snapshot day in 2013, over 47,000
clients received pharmacotherapy treatment for their opioid
dependence at 2,355 dosing points around Australia.
It shows there were 2,025 prescribers of opioid pharmacotherapy
in Australia in 2013, an increase of 15% from 2012.
'This means that, on average, each prescriber treated fewer
clients, with the ratio of clients per prescriber falling from 26
to 23 between 2012 and 2013,' said AIHW spokesperson Geoff
Most prescribers worked in the private sector (82%), and most
(71%) were authorised to prescribe more than 1 type of
Heroin is the most common opioid drug leading people to
'Our report shows that clients were about twice as likely to
report heroin as an opioid drug of dependence than they were for
all opioid pharmaceuticals combined; however this varied by
jurisdiction,' Mr Neideck said.
Methadone continues to be the most common pharmacotherapy drug,
with around two-thirds (68%) of clients treated with this drug. The
remaining third (32%) received 1 of 2 forms of buprenorphine.
'In recent years, we've seen a rise in the proportion of clients
receiving buprenorphine combined with naloxone, which is added to
deter injection of the medication,' Mr Neideck said.
The number of people receiving opioid pharmacotherapy treatment
almost doubled between 1998 (from around 25,000) and 2013 (around
47,000), but growth in client numbers slowed in recent years (to
less than 1% a year from 2010-2013).
As in previous years, opioid pharmacotherapy clients are getting
older on average. From 2006-2013 the proportion of clients aged
less than 30 more than halved (from 28% to 11%), and the proportion
of clients aged 50 and over more than doubled (from 8% to
'Most clients need to attend a dosing point regularly to take
their opioid pharmacotherapy drug under supervision, and most of
these are located in pharmacies,' Mr Neideck said.
The AIHW is a major national agency set up by the Australian
Government to provide reliable, regular and relevant information
and statistics on Australia's health and welfare.
Canberra, 13 June 2014
Further information: Mr Geoff Neideck,
AIHW, tel. (02) 6244 1163, mob. 0439 878 933
Full publication: National Opioid Pharmacotherapy Statistics 2013